Effects of GLP-1 on appetite and weight

Meera Shah, Adrian Vella

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Glucagon-like peptide 1 (GLP-1) is a cleavage product of the pre-proglucagon gene which is expressed in the α-cells of the pancreas, the L-cells of the intestine, and neurons located in the caudal brainstem and hypothalamus. GLP-1 is of relevance to appetite and weight maintenance because it has actions on the gastrointestinal tract as well as the direct regulation of appetite. It delays gastric emptying and gut motility in humans. In addition, interventricular injections of GLP-1 inhibit food intake, independent of the presence of food in the stomach or gastric emptying. Peripherally administered GLP-1 also affects the central regulation of feeding. It is therefore the synergistic actions of GLP-1 in the gut and brain, acting on both central and peripheral receptors that seem responsible for the effects of the hormone on satiety.

Original languageEnglish (US)
Pages (from-to)181-187
Number of pages7
JournalReviews in Endocrine and Metabolic Disorders
Volume15
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Glucagon-Like Peptide 1
Appetite
Weights and Measures
Gastric Emptying
Proglucagon
Enteroendocrine Cells
Appetite Regulation
Hypothalamus
Brain Stem
Gastrointestinal Tract
Pancreas
Stomach
Eating
Maintenance
Hormones
Neurons
Food
Injections
Brain
Genes

Keywords

  • Appetite
  • Bariatric surgery
  • Gastric accommodation
  • Gastric emptying
  • Satiety

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Effects of GLP-1 on appetite and weight. / Shah, Meera; Vella, Adrian.

In: Reviews in Endocrine and Metabolic Disorders, Vol. 15, No. 3, 2014, p. 181-187.

Research output: Contribution to journalArticle

@article{d0e5a9861353435a904f2412efe5034e,
title = "Effects of GLP-1 on appetite and weight",
abstract = "Glucagon-like peptide 1 (GLP-1) is a cleavage product of the pre-proglucagon gene which is expressed in the α-cells of the pancreas, the L-cells of the intestine, and neurons located in the caudal brainstem and hypothalamus. GLP-1 is of relevance to appetite and weight maintenance because it has actions on the gastrointestinal tract as well as the direct regulation of appetite. It delays gastric emptying and gut motility in humans. In addition, interventricular injections of GLP-1 inhibit food intake, independent of the presence of food in the stomach or gastric emptying. Peripherally administered GLP-1 also affects the central regulation of feeding. It is therefore the synergistic actions of GLP-1 in the gut and brain, acting on both central and peripheral receptors that seem responsible for the effects of the hormone on satiety.",
keywords = "Appetite, Bariatric surgery, Gastric accommodation, Gastric emptying, Satiety",
author = "Meera Shah and Adrian Vella",
year = "2014",
doi = "10.1007/s11154-014-9289-5",
language = "English (US)",
volume = "15",
pages = "181--187",
journal = "Reviews in Endocrine and Metabolic Disorders",
issn = "1389-9155",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Effects of GLP-1 on appetite and weight

AU - Shah, Meera

AU - Vella, Adrian

PY - 2014

Y1 - 2014

N2 - Glucagon-like peptide 1 (GLP-1) is a cleavage product of the pre-proglucagon gene which is expressed in the α-cells of the pancreas, the L-cells of the intestine, and neurons located in the caudal brainstem and hypothalamus. GLP-1 is of relevance to appetite and weight maintenance because it has actions on the gastrointestinal tract as well as the direct regulation of appetite. It delays gastric emptying and gut motility in humans. In addition, interventricular injections of GLP-1 inhibit food intake, independent of the presence of food in the stomach or gastric emptying. Peripherally administered GLP-1 also affects the central regulation of feeding. It is therefore the synergistic actions of GLP-1 in the gut and brain, acting on both central and peripheral receptors that seem responsible for the effects of the hormone on satiety.

AB - Glucagon-like peptide 1 (GLP-1) is a cleavage product of the pre-proglucagon gene which is expressed in the α-cells of the pancreas, the L-cells of the intestine, and neurons located in the caudal brainstem and hypothalamus. GLP-1 is of relevance to appetite and weight maintenance because it has actions on the gastrointestinal tract as well as the direct regulation of appetite. It delays gastric emptying and gut motility in humans. In addition, interventricular injections of GLP-1 inhibit food intake, independent of the presence of food in the stomach or gastric emptying. Peripherally administered GLP-1 also affects the central regulation of feeding. It is therefore the synergistic actions of GLP-1 in the gut and brain, acting on both central and peripheral receptors that seem responsible for the effects of the hormone on satiety.

KW - Appetite

KW - Bariatric surgery

KW - Gastric accommodation

KW - Gastric emptying

KW - Satiety

UR - http://www.scopus.com/inward/record.url?scp=84906263895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906263895&partnerID=8YFLogxK

U2 - 10.1007/s11154-014-9289-5

DO - 10.1007/s11154-014-9289-5

M3 - Article

C2 - 24811133

AN - SCOPUS:84906263895

VL - 15

SP - 181

EP - 187

JO - Reviews in Endocrine and Metabolic Disorders

JF - Reviews in Endocrine and Metabolic Disorders

SN - 1389-9155

IS - 3

ER -